Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Epileptic”

1,252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,252 results

Testing effectiveness (Phase 2)Ended earlyNCT05301894
What this trial is testing

Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

Who this might be right for
Epileptic EncephalopathyContinuous Spike and Wave During Sleep
Neurocrine Biosciences 19
Large-scale testing (Phase 3)Study completedNCT01162460
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Who this might be right for
Epilepsy
Bial - Portela C S.A. 815
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Not applicableUnknownNCT00625222
What this trial is testing

Transcranial Direct Current Stimulation (tDCS) As A Tool For Prospective Responder Identification Before Vagus Nerve Stimulation (VNS) Implantation

Who this might be right for
Epilepsy
University of Luebeck 70
Not applicableLooking for participantsNCT03233399
What this trial is testing

Modulating Movement Intention Via Cortical Stimulation

Who this might be right for
SeizuresSeizure DisorderPsychogenic Movement Disorder
NYU Langone Health 30
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05147571
What this trial is testing

RNS System NAUTILUS Study

Who this might be right for
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
NeuroPace 100
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Large-scale testing (Phase 3)Study completedNCT01393743
What this trial is testing

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Who this might be right for
Seizure Disorder Generalized Tonic Clonic
Eisai Inc. 163
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Not applicableActive Not RecruitingNCT05161494
What this trial is testing

Gait in Rare Diseases

Who this might be right for
Tuberous SclerosisSTXBP1 Encephalopathy With Epilepsy
Universiteit Antwerpen 70
Not applicableUnknownNCT01762215
What this trial is testing

Policy on Optimal Epilepsy Management

Who this might be right for
EpilepsySeizure Disorder
Northern California Institute of Research and Education 200
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Large-scale testing (Phase 3)Study completedNCT01389596
What this trial is testing

The Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Who this might be right for
Epilepsy, Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 295
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Not applicableStudy completedNCT03480555
What this trial is testing

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

Who this might be right for
Critical IllnessARDSSeptic Shock+3 more
King Abdullah International Medical Research Center 40
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Large-scale testing (Phase 3)Study completedNCT02408549
What this trial is testing

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 239
Load More Results